BioCentury | Jan 5, 2015
Financial News

CardioDx completes venture financing

CardioDx Inc. , Palo Alto, Calif. Business: Diagnostic Date completed: 2014-12-18 Type: Venture financing Raised: $35 million Investors: Alberta Investment Management; existing investors WIR Staff Diagnostic...
BioCentury | Jan 5, 2015
Financial News

CardioDx withdraws IPO

...Calif. Business: Diagnostic Date announced: 2014-12-23 Type: IPO Underwriters: Jefferies; Piper Jaffray; William Blair Note: CardioDx...
BioCentury | Dec 24, 2014
Financial News

CardioDx withdraws IPO

...fall, but it did not set terms (see BioCentury Extra, April 29). In November 2013, CardioDx...
...$14-$16, then postponed the offering. Jefferies; Piper Jaffray; and William Blair were to be underwriters. CardioDx...
BioCentury | Aug 20, 2014
Financial News

Dermatology play Dermira raises $51 million in series C

...indication (see BioCentury Extra, July 3) . Additionally, Dermira hired Andrew Guggenhime, former CFO of CardioDx Inc....
BioCentury | Jul 14, 2014
Clinical News

Corus CAD regulatory update

...that health care benefits companies Aetna Inc. and Aetna’s Coventry Health Care Inc. will cover CardioDx’s...
...test is available in the U.S. Patient samples are processed in the company’s CLIA-certified laboratory. CardioDx...
BioCentury | May 5, 2014
Financial News

CardioDx amends IPO

...To be raised: TBD Shares: TBD Price: TBD Underwriter: Jefferies; Piper Jaffray; William Blair Note: CardioDx...
...in the month, the company amended the offering to sell 5 million shares at $14-$16. CardioDx...
BioCentury | May 5, 2014
Company News

CardioDx management update

CardioDx Inc. , Palo Alto, Calif. Business: Diagnostic Hired: Melinda Griffith as head of corporate development and general counsel, formerly SVP of business development and product strategy at Clarient Inc. , which General Electric Co. acquired; and...
BioCentury | May 5, 2014
Company News

CardioDx board of directors update

CardioDx Inc. , Palo Alto, Calif. Business: Diagnostic Appointed: CFO Andrew Guggenhime; and James Tobin, formerly president and CEO of Boston Scientific Corp. WIR Staff Diagnostic...
BioCentury | Apr 30, 2014
Financial News

CardioDx revives IPO plans

...shares at $14-$16 and would have raised $75 million at the $15 midpoint. In November, CardioDx...
...or proposed number of shares. Jefferies; Piper Jaffray; and William Blair are listed as underwriters. CardioDx...
...23 genes and other patient characteristics, is covered under Medicare Part B. Separately on Tuesday, CardioDx...
BioCentury | Nov 18, 2013
Finance

Thanksgiving break

...Nov. 14, cardiovascular company Celladon Corp. confirmed it was postponing its IPO, and diagnostic company CardioDx Inc....
...depends on quantitative easing," Pinniger said. COMPANIES AND INSTITUTIONS Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. CardioDx Inc....
Items per page:
1 - 10 of 44
BioCentury | Jan 5, 2015
Financial News

CardioDx completes venture financing

CardioDx Inc. , Palo Alto, Calif. Business: Diagnostic Date completed: 2014-12-18 Type: Venture financing Raised: $35 million Investors: Alberta Investment Management; existing investors WIR Staff Diagnostic...
BioCentury | Jan 5, 2015
Financial News

CardioDx withdraws IPO

...Calif. Business: Diagnostic Date announced: 2014-12-23 Type: IPO Underwriters: Jefferies; Piper Jaffray; William Blair Note: CardioDx...
BioCentury | Dec 24, 2014
Financial News

CardioDx withdraws IPO

...fall, but it did not set terms (see BioCentury Extra, April 29). In November 2013, CardioDx...
...$14-$16, then postponed the offering. Jefferies; Piper Jaffray; and William Blair were to be underwriters. CardioDx...
BioCentury | Aug 20, 2014
Financial News

Dermatology play Dermira raises $51 million in series C

...indication (see BioCentury Extra, July 3) . Additionally, Dermira hired Andrew Guggenhime, former CFO of CardioDx Inc....
BioCentury | Jul 14, 2014
Clinical News

Corus CAD regulatory update

...that health care benefits companies Aetna Inc. and Aetna’s Coventry Health Care Inc. will cover CardioDx’s...
...test is available in the U.S. Patient samples are processed in the company’s CLIA-certified laboratory. CardioDx...
BioCentury | May 5, 2014
Financial News

CardioDx amends IPO

...To be raised: TBD Shares: TBD Price: TBD Underwriter: Jefferies; Piper Jaffray; William Blair Note: CardioDx...
...in the month, the company amended the offering to sell 5 million shares at $14-$16. CardioDx...
BioCentury | May 5, 2014
Company News

CardioDx management update

CardioDx Inc. , Palo Alto, Calif. Business: Diagnostic Hired: Melinda Griffith as head of corporate development and general counsel, formerly SVP of business development and product strategy at Clarient Inc. , which General Electric Co. acquired; and...
BioCentury | May 5, 2014
Company News

CardioDx board of directors update

CardioDx Inc. , Palo Alto, Calif. Business: Diagnostic Appointed: CFO Andrew Guggenhime; and James Tobin, formerly president and CEO of Boston Scientific Corp. WIR Staff Diagnostic...
BioCentury | Apr 30, 2014
Financial News

CardioDx revives IPO plans

...shares at $14-$16 and would have raised $75 million at the $15 midpoint. In November, CardioDx...
...or proposed number of shares. Jefferies; Piper Jaffray; and William Blair are listed as underwriters. CardioDx...
...23 genes and other patient characteristics, is covered under Medicare Part B. Separately on Tuesday, CardioDx...
BioCentury | Nov 18, 2013
Finance

Thanksgiving break

...Nov. 14, cardiovascular company Celladon Corp. confirmed it was postponing its IPO, and diagnostic company CardioDx Inc....
...depends on quantitative easing," Pinniger said. COMPANIES AND INSTITUTIONS Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. CardioDx Inc....
Items per page:
1 - 10 of 44